زائر
ytte-Mispst
ytte a tabets ntain eithe 100 mg 200 mg f mispst, a syntheti pstagandin E1 anag.
INDIATINS AND SAGE
ytte (mispst) is indiated f eding the isk f NSAID (nnsteida anti-infammaty dgs, inding aspiin)-inded gasti es in patients at high isk f mpiatins fm gasti e, eg, the edey and patients with nmitant debiitating disease, as we as patients at high isk f deveping gasti eatin, sh as patients with a histy f e. ytte has nt been shwn t ede the isk f ddena es in patients taking NSAIDs. ytte shd be taken f the datin f NSAID theapy. ytte has been shwn t ede the isk f gasti es in nted stdies f 3 mnths’ datin. It had n effet, mpaed t paeb, n gastintestina pain dismft assiated with NSAID se.
NTAINDIATINS
1)ytte shd nt be taken by pegnant wmen t ede the isk f es inded by nn-steida anti-infammaty dgs (NSAIDs).
YTTE (MISPST) ADMINISTATIN T WMEN WH AE PEGNANT AN ASE ABTIN, PEMATE
BITH, BITH DEFETS. TEINE PTE HAS BEEN EPTED WHEN YTTE WAS ADMINISTEED IN
PEGNANT WMEN T INDE AB T INDE ABTIN BEYND THE EIGHTH WEEK F PEGNANY
2)ytte shd nt be taken by anyne with a histy f aegy t pstagandins.
ytte has been pesibed f the patient’s speifi nditin, may nt be the et teatment f anthe pesn, and may be danges t the the pesn if she is wee t beme pegnant.
ADVESE EATINS
1)Gastintestina: ike diahea and abdmina pain.
2) Gynegia: Wmen wh eeived ytte ding inia tias epted the fwing gynegia disdes: sptting (0.7%), amps (0.6%), hypemenhea (0.5%), mensta disde (0.3%) and dysmenhea (0.1%).
DSAGE AND ADMINISTATIN
The emmended adt a dse f ytte f eding the isk f NSAID-inded gasti es is 200 mg f times daiy with fd. If this dse annt be teated, a dse f 100 mg an be sed.
من تجميعي
تحياتي لكم
اختكم رشـــــــــــــــا
ytte a tabets ntain eithe 100 mg 200 mg f mispst, a syntheti pstagandin E1 anag.
INDIATINS AND SAGE
ytte (mispst) is indiated f eding the isk f NSAID (nnsteida anti-infammaty dgs, inding aspiin)-inded gasti es in patients at high isk f mpiatins fm gasti e, eg, the edey and patients with nmitant debiitating disease, as we as patients at high isk f deveping gasti eatin, sh as patients with a histy f e. ytte has nt been shwn t ede the isk f ddena es in patients taking NSAIDs. ytte shd be taken f the datin f NSAID theapy. ytte has been shwn t ede the isk f gasti es in nted stdies f 3 mnths’ datin. It had n effet, mpaed t paeb, n gastintestina pain dismft assiated with NSAID se.
NTAINDIATINS
1)ytte shd nt be taken by pegnant wmen t ede the isk f es inded by nn-steida anti-infammaty dgs (NSAIDs).
YTTE (MISPST) ADMINISTATIN T WMEN WH AE PEGNANT AN ASE ABTIN, PEMATE
BITH, BITH DEFETS. TEINE PTE HAS BEEN EPTED WHEN YTTE WAS ADMINISTEED IN
PEGNANT WMEN T INDE AB T INDE ABTIN BEYND THE EIGHTH WEEK F PEGNANY
2)ytte shd nt be taken by anyne with a histy f aegy t pstagandins.
ytte has been pesibed f the patient’s speifi nditin, may nt be the et teatment f anthe pesn, and may be danges t the the pesn if she is wee t beme pegnant.
ADVESE EATINS
1)Gastintestina: ike diahea and abdmina pain.
2) Gynegia: Wmen wh eeived ytte ding inia tias epted the fwing gynegia disdes: sptting (0.7%), amps (0.6%), hypemenhea (0.5%), mensta disde (0.3%) and dysmenhea (0.1%).
DSAGE AND ADMINISTATIN
The emmended adt a dse f ytte f eding the isk f NSAID-inded gasti es is 200 mg f times daiy with fd. If this dse annt be teated, a dse f 100 mg an be sed.
من تجميعي
تحياتي لكم
اختكم رشـــــــــــــــا
التعديل الأخير بواسطة المشرف: